Clinical Trial Update: Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1b trial evaluating lenvatinib plus pembrolizumab in selected solid tumors has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lenvatinib (lenvatinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2021-05-20